Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California

 

Recent News and Articles on the Keywords: 0.29 + stem + biotech  Related to the article below (Last Update: 8/4/2008)

MorphoSys AG Reports Six Months 2008 Results
FOXBusiness - Jul 29, 2008
The resulting diluted earnings per share for the first six months of 2008 amounted to EUR 0.85 (H1 2007: Diluted earnings per share of EUR 0.29). ...FRA:MOR
MorphoSys AG Reports Six Months 2008
Ad-Hoc-News (Pressemitteilung), Germany - Jul 28, 2008
The resulting diluted earnings pershare for the first six months of 2008 amounted to EUR 0.85 (H1 2007:Diluted earnings per share of EUR 0.29). ...FRA:MOR

In order to show you the most relevant results, we have omitted some entries very similar to the 2 already displayed.
If you like, you can repeat the search with the omitted results included.

Source: Google News

Ethanol production by fermentation of sweet-stem sorghum juice using various yeast strains -
B Bulawayo, JM Bvochora, MI Muzondo, R Zvauya - World Journal of Microbiology and Biotechnology, 1996 - Springer
... World Journal of Microbiology & Biotechnology. ... ATCC-26602 0.29 0.37 0.46 0.39 0.10 ...
Yeast strain YEPS Sweet-stem Invertase activity sorghum juice (U ml-1) ATCC ...

Enhanced resistance to two stem borers in an aromatic rice containing a synthetic cryIA (b) gene -
B Ghareyazie, F Alinia, CA Menguito, LG Rubia, JM … - Molecular Breeding, 1997 - Springer
... Table 2. SSB resistance of T 2 booting stage plants in cut stem assays ... 827?6 ( ++ )
0.75 0.48 a 0.25 0.25 a 2.75 0.25 a 0.50 0.29 a 1.25 0.95 a 1.50 ...

Osteogenic Differentiation of Mouse Embryonic Stem Cells: Differential Gene Expression Analysis by … -
S Bourne, JM Polak, SPF Hughes, LDK Buttery - Tissue Engineering, 2004 - liebertonline.com
... Cbfa-1; 1:25 dilution) (Santa Cruz Biotech- nology), and ... Embryonic stem cell
characterization ... binding athanogene 1 (BAG1) AF020185 None 0.29 Cytoplasmid dynein ...

Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell … -
JR Passweg, A Tichelli, S Meyer-Monard, D Heim, M … - Leukemia, 2004 - nature.com
... purification and infusion (NK-DLI) in patients after haploidentical hematopoietic
stem cell transplantation ... 10 7 /kg (range 0.21?2.2) NK cells and 0.29 10 5 ...

High-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (ASCT) as … -
A Sauerbrey, S Bielack, B Kempf-Bielack, A Zoubek, … - nature.com
... our experience with high-dose chemotherapy (HDC) and autologous stem cell
transplantation ... months and the probability of overall survival was 0.29 ? 0.12 after ...

Research priorities for rice biotechnology -
RW Herdt - Rice Biotechnology, 1991 - books.google.com
... Page 46. Research Priorities for Rice Biotechnology 35 Table 2.5 ... Seedling vigor Apomixis
Shorter growth duration Insects Brown planthopper Yellow stem borer Gall ...

[PDF] Effect of adipose-derived mesenchymal stem and regenerative cells on lameness in dogs with chronic … -
LL Black, J Gaynor, D Gahring, C Adams, D Aron, S … - Vet Ther, 2007 - vetlearn.com
... Treatment Baseline 30 Days P Value* 60 Days: P Value* 90 Days: P Value* Lameness
Stem cell 2.44 ? 0.34 1.7 ? 0.2 .037 1.56 ? .034 .015 1.56 ? 0.29 .015 ...
-

[PDF] Antibacterial potentials of aqueous extract of Enantia chlorantha stem bark -
AA Adesokan, MA Akanji, MT Yakubu - African Journal of Biotechnology, 2007 - academicjournals.org
African Journal of Biotechnology Vol ... at varying concentrations of the aqueous extract
of E. chlorathia stem bark ... 50 mg/ml 7.00 ?0.29b 6.00 ?0.29b 5.20 ?0.12a ...

Main navigation -
A Terunuma, MB Shaya, MC Udey, JC Vogel, SPKRB … - Journal of Investigative Dermatology, 2004 - nature.com
... 26 wk; p values were 0.58, 0.40, and 0.29, respectively. In the real experimental
setting to test the long-term repopulation potential of stem cell candidates ...
-

… expression in greenhouse stem explants and in vitro-grown chrysanthemum stem thin cell layers -
JAT da Silva, S Fukai - African Journal of Biotechnology, 2003 - bioline.org.br
... African Journal of Biotechnology Vol ... 1.35 and 1.48 adventitious shoots (Figure 1H)
obtained from in vitro LIN, SNC and SNK stem tTCLs, respectively ... 1.10?0.29 c. ...

Source: Google Scholar
 
 

Biotechnology, Embryonic Stem Cell Research 'Here To Stay' As Political Issues, Opinion Piece Says

Article Date: 16 Nov 2006 - 9:00am (PST)
Biotechnology issues such as human embryonic stem cell research, which figured prominently in Missouri and elsewhere in the midterm elections, are "new kind[s]" of political issues that are not "going away," William Saletan, science and technology reporter for Slate magazine, writes in a Washington Post opinion piece. "If you block [embryonic stem cell research], you're closing off what might be the quickest path to saving many lives," Saletan writes, adding, "If you promote the research, along with the embryonic cloning that makes it therapeutically useful, you're messing with life's foundations" (Saletan, Washington Post, 11/12). In Missouri, voters approved a measure that amends the state constitution to ensure that stem cell research permitted under federal law is protected in the state and prohibits human cloning. About 51% of state voters supported the measure (Kaiser Daily Women's Health Policy Report, 11/8). The measure helped state Auditor Claire McCaskill (D) win a U.S. Senate race against incumbent Sen. Jim Talent (R-Mo.), Saletan writes, adding, "But biotech politics didn't start in Missouri, and it won't end there." Democrats have named embryonic stem cell research one of their top priorities for the 110th Congress, and Republicans are "scrambling for alternatives ... that tamper more ambitiously with the human recipe," Saletan writes. Advocates supporting and opposing embryonic stem cell research are attempting "to simplify the oncoming technologies" related to the research, with the "right ... equating [embryonic stem cell research] with abortion" and the "left treat[ing the] research like health care," according to Saletan. "Biotechnology is here to stay, even if humanity, as we know it, isn't," Saletan concludes (Washington Post, 11/12).

Article continues below and (thank you)
 
"Reprinted with permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
 

A New Maternal Diet Study Presented By Children's Hospital And Research Center-Oakland


A new study by scientists at Children's Hospital Oakland Research Institute (CHORI) is the first to show that a mother's diet during pregnancy influences the health of her grandchildren by changing the behavior of a specific gene. The study was conducted using mice of an unique strain called "viable yellow agouti" also known as Avy in scientific terms. These mice possess a gene that influences the color of their coats as well as their tendency to become obese and develop diabetes and cancer. The new research shows that the diet consumed by a pregnant Avy mouse affects the health of not only her pups, but also their pups - her grandchildren.

The study will be published in the November issue of the Proceedings of the National Academy of Sciences and was conducted by CHORI Scientist David Martin, M.D., and Assistant Scientist Kenneth Beckman, Ph.D., in collaboration with Drs. Jennifer Cropley and Catherine Suter from the Victor Chang Heart Institute in Sydney, Australia. In their experiments, the scientists fed some Avy mice a standard lab diet based on common foods consumed by humans. Other mice were fed this same diet supplemented with common nutritional supplements including folate, choline, betaine, vitamin B12, zinc and methionine.

The supplements were fed to the mice for a week during mid-pregnancy. The offspring were examined for their coat color, and female offspring were themselves mated again (without a supplemented diet) to produce a third generation of "grandchildren." The results showed that the supplements changed the behavior of the agouti gene in the first generation of pups, shifting their coats towards a brown color, and had the same effect on pups born in the next generation to mice that were not exposed to the supplemented diet.

"Although researchers have long known that there is a connection between a mother's diet and her children's health this is the first case in which the relationship between a mother's diet and the biology of her grandchildren has been mapped to a single gene and a defined diet," said David Martin, M.D., Scientist at CHORI. "Our work provides convincing evidence of complex transgenerational effects of nutrition on health, and provides an experimental model for exploring these relationships in detail."

Avy mice are an excellent system for study because all mice of this strain are genetically identical--as similar to each other as identical twins. However, mouse pups from a single litter differ from each other in their coat color (from yellow to brown), obesity (thinner to fatter), and susceptibility to cancer, and all of these varied traits can be traced back to the Avy version of the agouti gene. The mouse model also suggests that similar things can happen in humans, since our gene characteristics are very similar.

Although this study does not provide any prescriptive advice, it does offer significant evidence that health outcomes may be strongly influenced at the time of birth. "Our study highlights a layer of complexity about human development that needs to be thoroughly investigated," said Kenneth Beckman, Ph.D. Assistant Scientist at CHORI and a member of the Project EXPORT Center of Excellence in Nutritional Genomics, a PROGRAM PROJECT funded by the National Center on Minority Health and Health Disparities. "We found that even when we stopped providing specific supplements during pregnancy, the past effect of supplements persisted. Therefore, it is possible that the maternal diet could have implications that stretch over decades, perhaps even centuries."

###

About Children's Hospital & Research Center Oakland

Children's Hospital & Research Center Oakland is a designated Level I pediatric trauma center and the largest pediatric critical care facility in the region. The hospital has 181 licensed beds and 166 hospital-based physicians in 31 specialties, more than two thousand five hundred employees, and an operating budget of $287 million. The hospital's research institute has an annual budget of $41 million with more than 300 basic and clinic investigators. Children's Hospital Oakland Research Institute (CHORI) has made significant progress in areas including pediatric obesity, cancers, sickle cell disease, AIDS/HIV, hemophilia and cystic fibrosis.

Contact: Diana Yee
Children's Hospital & Research Center at Oakland
 
Google
Web www.iconocast.com
 
 
 

 

Continue News With: News5 ; News6 ; News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services. Home

 
 © 2002-2006

Keywords::

Contact Iconocast

Home Page